Trials / Completed
CompletedNCT03280420
Early Versus Late Catheter Removal in Patients With Acute Urinary Retention Secondary to BPH Under Tamsulosin Treatment
Early Versus Late Catheter Removal in Patients With Acute Urinary Retention Secondary to Benign Prostatic Hyperplasia Under Tamsulosin Treatment
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Salem Hassan Salem Mohamed · Academic / Other
- Sex
- Male
- Age
- —
- Healthy volunteers
- Accepted
Summary
The aim of this work is to compare between early (3days) and late(7days) removal of urinary catheter after acute urine retention in patients with Benign Prostatic Hyperplasia under Tamsulosin treatment.
Detailed description
This is a prospective randomized study, Men with acute urinary retention secondary to benign prostatic hyperplasia were catheterized and then, if they fulfilled the entry criteria, were randomly assigned to receive 0.4 mg tamsulosin hydrochloride for three days or seven days, After that the catheter was removed and the ability to void unaided assessed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Early catheter removal | Patients will receive selective alpha blocker ( tamsulosin 0.4mg ) once daily and the catheter will be removed after 3 days. After catheter removal, patients will be allowed to void and will be discharged home who will have a successful void more than 200 cc of urine. Patients who will fail to void will be re-catheterized and will be prepared for prostatectomy. |
| PROCEDURE | Late catheter removal | Patients will receive selective alpha blocker ( tamsulosin 0.4mg ) once daily and the catheter will be removed after 7 days. After catheter removal, patients will be allowed to void and will be discharged home who will have a successful void more than 200 cc of urine. Patients who will fail to void will be re-catheterized and will be prepared for prostatectomy. |
Timeline
- Start date
- 2017-03-12
- Primary completion
- 2017-09-16
- Completion
- 2017-09-16
- First posted
- 2017-09-12
- Last updated
- 2017-09-25
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT03280420. Inclusion in this directory is not an endorsement.